Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?
The NIH, which funded much of Moderna’s research on the COVID-19 vaccine, should be assertive in exerting control over the results of this research.

The NIH, which funded much of Moderna’s research on the COVID-19 vaccine, should be assertive in exerting control over the results of this research.

The discrepancy between past booster messaging and the current, broad recommendation has spawned public health communications problems.

COVID-19 vaccine hesitancy is further exacerbated by waves of misinformation promulgated on social media.

Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.

The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.

The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines.

The legal basis of Americans’ supposed right to a religious exemption to vaccination is less clear than such policies’ popularity would suggest.

Entities imposing COVID-19 vaccination mandates can take simple but significant steps to counter misuse of medical exemptions.
